AF
Cardiovascular
243 drugs in development·121 companies·1 clinical trial
Drug Pipeline by Phase
Approved(100)
Phase 3(49)
Phase 2(29)
Phase 1(14)
Preclinical(11)
Unknown(16)
BLA Filed(1)
| Drug | Company |
|---|---|
| belumosudil | Kadmon Holdings, Inc. (KDMN) |
N/A(2)
Phase 1/Phase 2(8)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| tecarfarin | Cadrenal Therapeutics, Inc. (CVKD) |
Phase 4(12)
Compare drugs
Frequently asked questions
How many drugs are in development for AF?
BioSniper tracks 243 drugs in development for AF across 121 companies.
How many clinical trials target AF?
There are 1 clinical trial targeting AF tracked by BioSniper.
Deep-dive into AF
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis